Your browser is no longer supported. Please, upgrade your browser.
Settings
KTTA [NASD]
Pasithea Therapeutics Corp.
Index- P/E- EPS (ttm)- Insider Own11.50% Shs Outstand13.21M Perf Week67.08%
Market Cap52.97M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float5.42M Perf Month35.47%
Income- PEG- EPS next Q- Inst Own9.00% Short Float4.87% Perf Quarter-
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.06 Perf Half Y-
Book/sh0.06 P/B70.35 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh1.56 P/C2.57 EPS next 5Y- ROE- 52W Range2.10 - 8.50 Perf YTD12.64%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-52.82% Beta-
Dividend %- Quick Ratio39.80 Sales past 5Y- Gross Margin- 52W Low90.95% ATR0.77
Employees1 Current Ratio39.80 Sales Q/Q- Oper. Margin- RSI (14)59.97 Volatility26.42% 13.31%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume1.21 Prev Close3.99
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume4.72M Price4.01
Recom- SMA2045.95% SMA5043.39% SMA20042.62% Volume5,730,956 Change0.50%
Nov-24-21 08:52AM  
07:34AM  
Nov-23-21 11:39AM  
11:31AM  
08:00AM  
05:02AM  
Nov-17-21 08:00AM  
07:30AM  
Nov-11-21 08:00AM  
Nov-09-21 08:00AM  
Oct-27-21 11:40AM  
07:45AM  
07:15AM  
Oct-18-21 01:37PM  
11:07AM  
Oct-14-21 09:13AM  
07:45AM  
07:15AM  
Oct-11-21 10:08AM  
08:20AM  
06:50AM  
Oct-05-21 08:37AM  
Oct-04-21 08:00AM  
Sep-29-21 04:30PM  
Sep-20-21 12:51PM  
Sep-17-21 04:05PM  
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.